House Energy & Commerce
Executive Summary
Chairman in the 104th Congress will not be current Ranking Republican Moorhead (Calif.), according to staffers. Moorhead will not contest Rep. Bliley's (R-Va.) bid to become full committee chair and instead will chair the House Judiciary/Patents Subcommittee. With Bliley's ascent to the chairmanship of Energy & Commerce, Rep. Bilirakis (R-Fla.) becomes the next logical choice to head the panel's Health & the Environment Subcommittee, where currently he holds the number two minority spot behind Bliley. Reps. Fields (R-Tex.) and Oxley (R-Ohio), who have more committee seniority than Bilirakis and could choose to head the Health Subcommittee, are eyeing other chairmanships, according to staffers. The Rowland/Bilirakis bill of the 103rd Congress could serve as a blueprint for more restricted health reform legislation in the house during the 104th, according to Bilirakis aides
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth